Viking Therapeutics (NASDAQ: VKTX)
Viking Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Viking Therapeutics Company Info
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.
News & Analysis
2 Beaten-Down Stocks That Could Rocket 142% to 222% Higher, According to Wall Street Analysts
Investment bank analysts up and down Wall Street are pounding the table on these stocks.
Why Viking Therapeutics Stock Popped Nearly 4% Today
The company's obesity drug could have more potential than originally believed.
Billionaire Stanley Druckenmiller Just Bought the Dip on This Beaten-Down GLP-1 Stock (Hint: It's Not Eli Lilly or Novo Nordisk)
Druckenmiller's Duquesne Family Office just scooped up a popular weight-loss stock.
Why Is Viking Therapeutics Stock Crashing, and Is It a Buying Opportunity?
The market for weight loss treatments is growing significantly and is forecast to continue increasing for several years.
Viking Therapeutics: What's Next?
Viking's 40% crash over fixable dosing issues ignores its best-in-class 12.2% oral weight loss and Phase 3 momentum.
2 Biotech Stocks That Could Soar 21% and 245% According to Wall Street's Top Analysts
These companies aren't performing as badly as their stock-market performances this year suggest.
Here's Why Shares in Viking Therapeutics Crashed This Week
The phase 2 trial results for its key drug didn't pan out quite as planned.
Is Beaten-Down Viking Therapeutics Stock a Buy on the Dip?
A disappointing result for its oral obesity candidate hammered the stock price.
Valuation
Earnings Transcripts
Viking (VKTX) Q2 2025 Earnings Call Transcript
None
Viking Therapeutics (VKTX) Q2 2022 Earnings Call Transcript
VKTX earnings call for the period ending June 30, 2022.
Viking Therapeutics (VKTX) Q1 2022 Earnings Call Transcript
VKTX earnings call for the period ending March 31, 2022.
Viking Therapeutics (VKTX) Q4 2021 Earnings Call Transcript
VKTX earnings call for the period ending December 31, 2021.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.